193 related articles for article (PubMed ID: 30933310)
1. Release parameters during progressive degeneration of dopamine neurons in a mouse model reveal earlier impairment of spontaneous than forced behaviors.
Chen YH; Hsieh TH; Kuo TT; Kao JH; Ma KH; Huang EY; Chou YC; Olson L; Hoffer BJ
J Neurochem; 2019 Jul; 150(1):56-73. PubMed ID: 30933310
[TBL] [Abstract][Full Text] [Related]
2. Neuronal KIF5b deletion induces striatum-dependent locomotor impairments and defects in membrane presentation of dopamine D2 receptors.
Cromberg LE; Saez TMM; Otero MG; Tomasella E; Alloatti M; Damianich A; Pozo Devoto V; Ferrario J; Gelman D; Rubinstein M; Falzone TL
J Neurochem; 2019 May; 149(3):362-380. PubMed ID: 30664247
[TBL] [Abstract][Full Text] [Related]
3. Altered glutamate release in the dorsal striatum of the MitoPark mouse model of Parkinson's disease.
Farrand AQ; Gregory RA; Bäckman CM; Helke KL; Boger HA
Brain Res; 2016 Nov; 1651():88-94. PubMed ID: 27659966
[TBL] [Abstract][Full Text] [Related]
4. Action potential and calcium dependence of tonic somatodendritic dopamine release in the Substantia Nigra pars compacta.
Yee AG; Forbes B; Cheung PY; Martini A; Burrell MH; Freestone PS; Lipski J
J Neurochem; 2019 Feb; 148(4):462-479. PubMed ID: 30203851
[TBL] [Abstract][Full Text] [Related]
5. Progressive parkinsonism due to mitochondrial impairment: Lessons from the MitoPark mouse model.
Beckstead MJ; Howell RD
Exp Neurol; 2021 Jul; 341():113707. PubMed ID: 33753138
[TBL] [Abstract][Full Text] [Related]
6. Fingolimod (FTY720) is not protective in the subacute MPTP mouse model of Parkinson's disease and does not lead to a sustainable increase of brain-derived neurotrophic factor.
Komnig D; Dagli TC; Habib P; Zeyen T; Schulz JB; Falkenburger BH
J Neurochem; 2018 Dec; 147(5):678-691. PubMed ID: 30152864
[TBL] [Abstract][Full Text] [Related]
7. Dopamine Release Neuroenergetics in Mouse Striatal Slices.
Msackyi M; Chen Y; Tsering W; Wang N; Zhang H
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731799
[TBL] [Abstract][Full Text] [Related]
8. Astrocyte support is important for the compensatory potential of the nigrostriatal system neurons during early neurodegeneration.
Kuter K; Olech Ł; Głowacka U; Paleczna M
J Neurochem; 2019 Jan; 148(1):63-79. PubMed ID: 30295916
[TBL] [Abstract][Full Text] [Related]
9. Pitx3 deficiency produces decreased dopamine signaling and induces motor deficits in Pitx3(-/-) mice.
Le W; Zhang L; Xie W; Li S; Dani JA
Neurobiol Aging; 2015 Dec; 36(12):3314-3320. PubMed ID: 26363812
[TBL] [Abstract][Full Text] [Related]
10. Compromised Dopaminergic Encoding of Reward Accompanying Suppressed Willingness to Overcome High Effort Costs Is a Prominent Prodromal Characteristic of the Q175 Mouse Model of Huntington's Disease.
Covey DP; Dantrassy HM; Zlebnik NE; Gildish I; Cheer JF
J Neurosci; 2016 May; 36(18):4993-5002. PubMed ID: 27147652
[TBL] [Abstract][Full Text] [Related]
11. Mice with dopaminergic neuron-specific deletion of DTNBP-1 gene show blunted nucleus accumbens dopamine release and associated behaviors.
Bhardwaj SK; Cui Q; Moquin L; Gratton A; Giros B; Srivastava LK
Neuropharmacology; 2021 Feb; 184():108440. PubMed ID: 33340529
[TBL] [Abstract][Full Text] [Related]
12. L-Dopa induced dyskinesias in Parkinsonian mice: Disease severity or L-Dopa history.
Shan L; Diaz O; Zhang Y; Ladenheim B; Cadet JL; Chiang YH; Olson L; Hoffer BJ; Bäckman CM
Brain Res; 2015 Aug; 1618():261-9. PubMed ID: 26086365
[TBL] [Abstract][Full Text] [Related]
13. Dopaminergic and behavioral correlates of progressive lesioning of the nigrostriatal pathway with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Goldberg NR; Haack AK; Lim NS; Janson OK; Meshul CK
Neuroscience; 2011 Apr; 180():256-71. PubMed ID: 21335067
[TBL] [Abstract][Full Text] [Related]
14. Progressively disrupted somatodendritic morphology in dopamine neurons in a mouse Parkinson's model.
Lynch WB; Tschumi CW; Sharpe AL; Branch SY; Chen C; Ge G; Li S; Beckstead MJ
Mov Disord; 2018 Dec; 33(12):1928-1937. PubMed ID: 30440089
[TBL] [Abstract][Full Text] [Related]
15. Impaired nigrostriatal function precedes behavioral deficits in a genetic mitochondrial model of Parkinson's disease.
Good CH; Hoffman AF; Hoffer BJ; Chefer VI; Shippenberg TS; Bäckman CM; Larsson NG; Olson L; Gellhaar S; Galter D; Lupica CR
FASEB J; 2011 Apr; 25(4):1333-44. PubMed ID: 21233488
[TBL] [Abstract][Full Text] [Related]
16. Voluntary exercise delays progressive deterioration of markers of metabolism and behavior in a mouse model of Parkinson's disease.
Lai JH; Chen KY; Wu JC; Olson L; Brené S; Huang CZ; Chen YH; Kang SJ; Ma KH; Hoffer BJ; Hsieh TH; Chiang YH
Brain Res; 2019 Oct; 1720():146301. PubMed ID: 31226324
[TBL] [Abstract][Full Text] [Related]
17. The histone deacetylase inhibitor nicotinamide exacerbates neurodegeneration in the lactacystin rat model of Parkinson's disease.
Harrison IF; Powell NM; Dexter DT
J Neurochem; 2019 Jan; 148(1):136-156. PubMed ID: 30269333
[TBL] [Abstract][Full Text] [Related]
18. Calbindin-D28K Limits Dopamine Release in Ventral but Not Dorsal Striatum by Regulating Ca
Brimblecombe KR; Vietti-Michelina S; Platt NJ; Kastli R; Hnieno A; Gracie CJ; Cragg SJ
ACS Chem Neurosci; 2019 Aug; 10(8):3419-3426. PubMed ID: 31361457
[TBL] [Abstract][Full Text] [Related]
19. Voluntary Exercise Boosts Striatal Dopamine Release: Evidence for the Necessary and Sufficient Role of BDNF.
Bastioli G; Arnold JC; Mancini M; Mar AC; Gamallo-Lana B; Saadipour K; Chao MV; Rice ME
J Neurosci; 2022 Jun; 42(23):4725-4736. PubMed ID: 35577554
[TBL] [Abstract][Full Text] [Related]
20. Delayed Dopamine Dysfunction and Motor Deficits in Female Parkinson Model Mice.
Chen YH; Wang V; Huang EY; Chou YC; Kuo TT; Olson L; Hoffer BJ
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
